Obesity and hepatocellular carcinoma: Hype and reality-Reference-Cited by-同舟云学术

Obesity and hepatocellular carcinoma: Hype and reality

Published:2014-06-20 Issue:3 Volume:60 Page:779-781
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

El-Serag Hashem B.¹,Kanwal Fasiha¹

Affiliation:

1. Section of Gastroenterology and Hepatology; Michael E DeBakey VA Medical Center and Baylor College of Medicine, and Houston VA HSR&D Center for Innovations in Quality, Effectiveness and Safety; Houston TX

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27172/fullpdf

Reference14 articles.

1. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer;Aleksandrova;Hepatology,2014

2. Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence;Saunders;Aliment Pharmacol Ther,2010

3. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort;Schlesinger;Ann Oncol,2013

4. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States;Welzel;Am J Gastroenterol,2013

5. Conceptual problems in the definition and interpretation of attributable fractions;Greenland;Am J Epidemiol,1988

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Don’t Judge a Book by Its Cover: The Role of Statins in Liver Cancer;Cancers;2023-10-22

2. Bioimpedance analysis predicts the etiology of cirrhosis in a prospective cohort study;Hepatology Communications;2023-09-11

3. Walking and taking vitamin C alleviates oxidative stress and inflammation in overweight students, even in the short-term;Frontiers in Public Health;2022-10-05

4. Ezetimibe and Cancer: Is There a Connection?;Frontiers in Pharmacology;2022-07-18

5. Breakthroughs in therapies for NASH and remaining challenges;Journal of Hepatology;2022-06